Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
Karnes JH, McDonough CW, Gong Y, Vo TT, Langaee TY, Chapman AB, Gums JG, Beitelshees AL, Bailey KR, Del-Aguila JL, Boerwinkle EA, Pepine CJ, Turner ST, Johnson JA, Cooper-DeHoff RM.
Karnes JH, et al. Among authors: turner st.
Pharmacogenomics J. 2013 Oct;13(5):430-6. doi: 10.1038/tpj.2012.34. Epub 2012 Aug 21.
Pharmacogenomics J. 2013.
PMID: 22907731
Free PMC article.
Clinical Trial.